<?xml version='1.0' encoding='UTF-8'?>
<uniprot>
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2015-01-07" version="156">
<accession>P49137</accession>
<accession>Q5SY30</accession>
<accession>Q5SY41</accession>
<accession>Q8IYD6</accession>
<name>MAPK2_HUMAN</name>
<protein>
<recommendedName>
<fullName>MAP kinase-activated protein kinase 2</fullName>
<shortName>MAPK-activated protein kinase 2</shortName>
<shortName>MAPKAP kinase 2</shortName>
<shortName>MAPKAP-K2</shortName>
<shortName>MAPKAPK-2</shortName>
<shortName>MK-2</shortName>
<shortName>MK2</shortName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">MAPKAPK2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Biochem. Biophys. Res. Commun." volume="200" first="1118" last="1124">
<title>The primary structure of a human MAP kinase activated protein kinase 2.</title>
<authorList>
<person name="Zu Y.-L."/>
<person name="Wu F."/>
<person name="Gilchrist A."/>
<person name="Ai Y."/>
<person name="Labadia M.E."/>
<person name="Huang C.K."/>
</authorList>
<dbReference type="PubMed" id="8179591"/>
<dbReference type="DOI" id="10.1006/bbrc.1994.1566"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Skin</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1993" name="Biochem. J." volume="296" first="843" last="849">
<title>The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2.</title>
<authorList>
<person name="Stokoe D."/>
<person name="Caudwell B."/>
<person name="Cohen P.T.W."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="8280084"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 5-400 (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="1517" last="1520">
<title>Small heat shock proteins are molecular chaperones.</title>
<authorList>
<person name="Jakob U."/>
<person name="Gaestel M."/>
<person name="Engel K."/>
<person name="Buchner J."/>
</authorList>
<dbReference type="PubMed" id="8093612"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF HSPB1</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="5920" last="5930">
<title>Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2.</title>
<authorList>
<person name="Ben-Levy R."/>
<person name="Leighton I.A."/>
<person name="Doza Y.N."/>
<person name="Attwood P."/>
<person name="Morrice N."/>
<person name="Marshall C.J."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="8846784"/>
</citation>
<scope>PHOSPHORYLATION AT SER-9; THR-25; THR-222; SER-272 AND THR-334</scope>
<scope>MUTAGENESIS OF ASP-207; THR-222; SER-272 AND THR-334</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="FEBS Lett." volume="392" first="209" last="214">
<title>A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress.</title>
<authorList>
<person name="Clifton A.D."/>
<person name="Young P.R."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="8774846"/>
<dbReference type="DOI" id="10.1016/0014-5793(96)00816-2"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF HSPB1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="18947" last="18956">
<title>Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation.</title>
<authorList>
<person name="Rogalla T."/>
<person name="Ehrnsperger M."/>
<person name="Preville X."/>
<person name="Kotlyarov A."/>
<person name="Lutsch G."/>
<person name="Ducasse C."/>
<person name="Paul C."/>
<person name="Wieske M."/>
<person name="Arrigo A.P."/>
<person name="Buchner J."/>
<person name="Gaestel M."/>
</authorList>
<dbReference type="PubMed" id="10383393"/>
<dbReference type="DOI" id="10.1074/jbc.274.27.18947"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF HSPB1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="6505" last="6514">
<title>Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs.</title>
<authorList>
<person name="Rousseau S."/>
<person name="Morrice N."/>
<person name="Peggie M."/>
<person name="Campbell D.G."/>
<person name="Gaestel M."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="12456657"/>
<dbReference type="DOI" id="10.1093/emboj/cdf639"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF HNRNPA0</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="14793" last="14800">
<title>Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2).</title>
<authorList>
<person name="Werz O."/>
<person name="Szellas D."/>
<person name="Steinhilber D."/>
<person name="Radmark O."/>
</authorList>
<dbReference type="PubMed" id="11844797"/>
<dbReference type="DOI" id="10.1074/jbc.M111945200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF LOX5</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="301" first="665" last="670">
<title>Affinity purification of ARE-binding proteins identifies polyA-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization.</title>
<authorList>
<person name="Bollig F."/>
<person name="Winzen R."/>
<person name="Gaestel M."/>
<person name="Kostka S."/>
<person name="Resch K."/>
<person name="Holtmann H."/>
</authorList>
<dbReference type="PubMed" id="12565831"/>
<dbReference type="DOI" id="10.1016/S0006-291X(03)00015-9"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PABPC1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Cell. Signal." volume="15" first="993" last="1001">
<title>MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils.</title>
<authorList>
<person name="Coxon P.Y."/>
<person name="Rane M.J."/>
<person name="Uriarte S."/>
<person name="Powell D.W."/>
<person name="Singh S."/>
<person name="Butt W."/>
<person name="Chen Q."/>
<person name="McLeish K.R."/>
</authorList>
<dbReference type="PubMed" id="14499342"/>
<dbReference type="DOI" id="10.1016/S0898-6568(03)00074-3"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="7177" last="7188">
<title>Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.</title>
<authorList>
<person name="Tran H."/>
<person name="Maurer F."/>
<person name="Nagamine Y."/>
</authorList>
<dbReference type="PubMed" id="14517288"/>
<dbReference type="DOI" id="10.1128/MCB.23.20.7177-7188.2003"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF ELAVL1</scope>
<scope>MUTAGENESIS OF LYS-93; THR-222 AND THR-334</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="1313" last="1324">
<title>MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay.</title>
<authorList>
<person name="Stoecklin G."/>
<person name="Stubbs T."/>
<person name="Kedersha N."/>
<person name="Wax S."/>
<person name="Rigby W.F."/>
<person name="Blackwell T.K."/>
<person name="Anderson P."/>
</authorList>
<dbReference type="PubMed" id="15014438"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600163"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF ZFP36</scope>
<scope>MUTAGENESIS OF THR-222 AND THR-334</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="FEBS Lett." volume="564" first="205" last="211">
<title>P66(ShcA) interacts with MAPKAP kinase 2 and regulates its activity.</title>
<authorList>
<person name="Yannoni Y.M."/>
<person name="Gaestel M."/>
<person name="Lin L.L."/>
</authorList>
<dbReference type="PubMed" id="15094067"/>
<dbReference type="DOI" id="10.1016/S0014-5793(04)00351-5"/>
</citation>
<scope>INTERACTION WITH PHC2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Mol. Cell" volume="17" first="37" last="48">
<title>MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation.</title>
<authorList>
<person name="Manke I.A."/>
<person name="Nguyen A."/>
<person name="Lim D."/>
<person name="Stewart M.Q."/>
<person name="Elia A.E."/>
<person name="Yaffe M.B."/>
</authorList>
<dbReference type="PubMed" id="15629715"/>
<dbReference type="DOI" id="10.1016/j.molcel.2004.11.021"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CDC25B AND CDC25C</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="713" last="726">
<title>MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration.</title>
<authorList>
<person name="Kobayashi M."/>
<person name="Nishita M."/>
<person name="Mishima T."/>
<person name="Ohashi K."/>
<person name="Mizuno K."/>
</authorList>
<dbReference type="PubMed" id="16456544"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600973"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF LIMK1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="782" last="791">
<title>Phosphorylation of HSF1 by MAPK-activated protein kinase 2 on serine 121, inhibits transcriptional activity and promotes HSP90 binding.</title>
<authorList>
<person name="Wang X."/>
<person name="Khaleque M.A."/>
<person name="Zhao M.J."/>
<person name="Zhong R."/>
<person name="Gaestel M."/>
<person name="Calderwood S.K."/>
</authorList>
<dbReference type="PubMed" id="16278218"/>
<dbReference type="DOI" id="10.1074/jbc.M505822200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF HSF1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Biochem. Biophys. Res. Commun." volume="358" first="170" last="175">
<title>MAPKAPK2-mediated LSP1 phosphorylation and FMLP-induced neutrophil polarization.</title>
<authorList>
<person name="Wu Y."/>
<person name="Zhan L."/>
<person name="Ai Y."/>
<person name="Hannigan M."/>
<person name="Gaestel M."/>
<person name="Huang C.-K."/>
<person name="Madri J.A."/>
</authorList>
<dbReference type="PubMed" id="17481585"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2007.04.104"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF LSP1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Biochem. J." volume="409" first="711" last="722">
<title>Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex.</title>
<authorList>
<person name="Mendoza H."/>
<person name="Campbell D.G."/>
<person name="Burness K."/>
<person name="Hastie J."/>
<person name="Ronkina N."/>
<person name="Shim J.H."/>
<person name="Arthur J.S."/>
<person name="Davis R.J."/>
<person name="Gaestel M."/>
<person name="Johnson G.L."/>
<person name="Ghosh S."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="18021073"/>
<dbReference type="DOI" id="10.1042/BJ20071149"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TAB3</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Mol. Cell" volume="40" first="34" last="49">
<title>DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization.</title>
<authorList>
<person name="Reinhardt H.C."/>
<person name="Hasskamp P."/>
<person name="Schmedding I."/>
<person name="Morandell S."/>
<person name="van Vugt M.A."/>
<person name="Wang X."/>
<person name="Linding R."/>
<person name="Ong S.E."/>
<person name="Weaver D."/>
<person name="Carr S.A."/>
<person name="Yaffe M.B."/>
</authorList>
<dbReference type="PubMed" id="20932473"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.09.018"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF HNRNPA0 AND PARN</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="Blood" volume="117" first="2527" last="2537">
<title>MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation.</title>
<authorList>
<person name="Chang E."/>
<person name="Heo K.S."/>
<person name="Woo C.H."/>
<person name="Lee H."/>
<person name="Le N.T."/>
<person name="Thomas T.N."/>
<person name="Fujiwara K."/>
<person name="Abe J."/>
</authorList>
<dbReference type="PubMed" id="21131586"/>
<dbReference type="DOI" id="10.1182/blood-2010-08-302281"/>
</citation>
<scope>SUMOYLATION AT LYS-353</scope>
<scope>MUTAGENESIS OF LYS-353</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Front. Biosci." volume="13" first="5511" last="5521">
<title>MK2 and MK3--a pair of isoenzymes?</title>
<authorList>
<person name="Ronkina N."/>
<person name="Kotlyarov A."/>
<person name="Gaestel M."/>
</authorList>
<dbReference type="PubMed" id="18508601"/>
<dbReference type="DOI" id="10.2741/3095"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="37401" last="37405">
<title>Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export.</title>
<authorList>
<person name="Meng W."/>
<person name="Swenson L.L."/>
<person name="Fitzgibbon M.J."/>
<person name="Hayakawa K."/>
<person name="Ter Haar E."/>
<person name="Behrens A.E."/>
<person name="Fulghum J.R."/>
<person name="Lippke J.A."/>
</authorList>
<dbReference type="PubMed" id="12171911"/>
<dbReference type="DOI" id="10.1074/jbc.C200418200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH ADP AND STAUROSPORINE</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="Structure" volume="11" first="627" last="636">
<title>Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme.</title>
<authorList>
<person name="Underwood K.W."/>
<person name="Parris K.D."/>
<person name="Federico E."/>
<person name="Mosyak L."/>
<person name="Czerwinski R.M."/>
<person name="Shane T."/>
<person name="Taylor M."/>
<person name="Svenson K."/>
<person name="Liu Y."/>
<person name="Hsiao C.L."/>
<person name="Wolfrom S."/>
<person name="Maguire M."/>
<person name="Malakian K."/>
<person name="Telliez J.B."/>
<person name="Lin L.L."/>
<person name="Kriz R.W."/>
<person name="Seehra J."/>
<person name="Somers W.S."/>
<person name="Stahl M.L."/>
</authorList>
<dbReference type="PubMed" id="12791252"/>
<dbReference type="DOI" id="10.1016/S0969-2126(03)00092-3"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS)</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Bioorg. Med. Chem. Lett." volume="17" first="4664" last="4669">
<title>The discovery of carboline analogs as potent MAPKAP-K2 inhibitors.</title>
<authorList>
<person name="Wu J.P."/>
<person name="Wang J."/>
<person name="Abeywardane A."/>
<person name="Andersen D."/>
<person name="Emmanuel M."/>
<person name="Gautschi E."/>
<person name="Goldberg D.R."/>
<person name="Kashem M.A."/>
<person name="Lukas S."/>
<person name="Mao W."/>
<person name="Martin L."/>
<person name="Morwick T."/>
<person name="Moss N."/>
<person name="Pargellis C."/>
<person name="Patel U.R."/>
<person name="Patnaude L."/>
<person name="Peet G.W."/>
<person name="Skow D."/>
<person name="Snow R.J."/>
<person name="Ward Y."/>
<person name="Werneburg B."/>
<person name="White A."/>
</authorList>
<dbReference type="PubMed" id="17576063"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2007.05.101"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 41-364 IN COMPLEX WITH CARBOLINE-BASED INHIBITORS</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="9733" last="9739">
<title>Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimer.</title>
<authorList>
<person name="ter Haar E."/>
<person name="Prabhakar P."/>
<person name="Liu X."/>
<person name="Lepre C."/>
</authorList>
<dbReference type="PubMed" id="17255097"/>
<dbReference type="DOI" id="10.1074/jbc.M611165200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (4.0 ANGSTROMS) IN COMPLEX WITH MAPK14</scope>
<scope>INTERACTION WITH MAPK14</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="14684" last="14684">
<authorList>
<person name="ter Haar E."/>
<person name="Prabhakar P."/>
<person name="Liu X."/>
<person name="Lepre C."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="J. Med. Chem." volume="50" first="2647" last="2654">
<title>Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).</title>
<authorList>
<person name="Anderson D.R."/>
<person name="Meyers M.J."/>
<person name="Vernier W.F."/>
<person name="Mahoney M.W."/>
<person name="Kurumbail R.G."/>
<person name="Caspers N."/>
<person name="Poda G.I."/>
<person name="Schindler J.F."/>
<person name="Reitz D.B."/>
<person name="Mourey R.J."/>
</authorList>
<dbReference type="PubMed" id="17480064"/>
<dbReference type="DOI" id="10.1021/jm0611004"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.8 ANGSTROMS) OF 45-371 IN COMPLEX WITH PYRROLOPYRIDINE INHIBITORS</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="J. Mol. Biol." volume="369" first="735" last="745">
<title>Structural basis for a high affinity inhibitor bound to protein kinase MK2.</title>
<authorList>
<person name="Hillig R.C."/>
<person name="Eberspaecher U."/>
<person name="Monteclaro F."/>
<person name="Huber M."/>
<person name="Nguyen D."/>
<person name="Mengel A."/>
<person name="Muller-Tiemann B."/>
<person name="Egner U."/>
</authorList>
<dbReference type="PubMed" id="17449059"/>
<dbReference type="DOI" id="10.1016/j.jmb.2007.03.004"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 41-364 IN COMPLEX WITH PYRROLOPYRIDINE INHIBITOR</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="6353" last="6358">
<title>Molecular basis of MAPK-activated protein kinase 2:p38 assembly.</title>
<authorList>
<person name="White A."/>
<person name="Pargellis C.A."/>
<person name="Studts J.M."/>
<person name="Werneburg B.G."/>
<person name="Farmer B.T. II"/>
</authorList>
<dbReference type="PubMed" id="17395714"/>
<dbReference type="DOI" id="10.1073/pnas.0701679104"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 47-400 IN COMPLEX WITH MAPK14</scope>
<scope>INTERACTION WITH MAPK14</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] GLY-173 AND SER-361</scope>
</reference>
<comment type="function">
<text evidence="12 13 15 16 17 18 19 21 22 23 29 31 32 34 35 36">Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, ELAVL1, HNRNPA0, HSF1, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilize GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3.</text>
</comment>
<comment type="catalytic activity">
<text evidence="14 36">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text>Activated following phosphorylation by p38-alpha/MAPK14 following various stresses. Inhibited following sumoylation. Specifically inhibited by pyrrolopyridine inhibitors.</text>
</comment>
<comment type="subunit">
<text evidence="14 20 24 26 27 28 30">Heterodimer with p38-alpha/MAPK14. The heterodimer with p38-alpha/MAPK14 forms a stable complex: molecules are positioned 'face to face' so that the ATP-binding sites of both kinases are at the heterodimer interface. Interacts with PHC2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-993299"/>
<interactant intactId="EBI-719620">
<id>Q00613</id>
<label>HSF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-993299"/>
<interactant intactId="EBI-352682">
<id>P04792</id>
<label>HSPB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-993299"/>
<interactant intactId="EBI-73946">
<id>Q16539</id>
<label>MAPK14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-993299"/>
<interactant intactId="EBI-642357">
<id>Q9QWH1</id>
<label>Phc2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="32">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="32">Nucleus</location>
</subcellularLocation>
<text>Phosphorylation and subsequent activation releases the autoinhibitory helix, resulting in the export from the nucleus into the cytoplasm.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P49137-1</id>
<name>1</name>
<sequence type="displayed"/>
<note>Has a nuclear localization signal.</note>
</isoform>
<isoform>
<id>P49137-2</id>
<name>2</name>
<sequence type="described" ref="VSP_004910"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Expressed in all tissues examined.</text>
</comment>
<comment type="PTM">
<text evidence="33">Sumoylation inhibits the protein kinase activity.</text>
</comment>
<comment type="PTM">
<text evidence="37">Phosphorylated and activated by MAP kinase p38-alpha/MAPK14 at Thr-222, Ser-272 and Thr-334.</text>
</comment>
<comment type="similarity">
<text evidence="39">Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family.</text>
</comment>
<comment type="similarity">
<text evidence="11">Contains 1 protein kinase domain.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/MAPKAPK2ID41295ch1q32.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="U12779">
<property type="protein sequence ID" value="AAA20851.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL591846">
<property type="protein sequence ID" value="CAI13543.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL591846">
<property type="protein sequence ID" value="CAI13544.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471100">
<property type="protein sequence ID" value="EAW93526.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471100">
<property type="protein sequence ID" value="EAW93529.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC036060">
<property type="protein sequence ID" value="AAH36060.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC052584">
<property type="protein sequence ID" value="AAH52584.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X75346">
<property type="protein sequence ID" value="CAA53094.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1466.1">
<molecule id="P49137-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31001.1">
<molecule id="P49137-1"/>
</dbReference>
<dbReference type="PIR" id="JC2204">
<property type="entry name" value="JC2204"/>
</dbReference>
<dbReference type="PIR" id="S39793">
<property type="entry name" value="S39793"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004750.1">
<molecule id="P49137-2"/>
<property type="nucleotide sequence ID" value="NM_004759.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_116584.2">
<molecule id="P49137-1"/>
<property type="nucleotide sequence ID" value="NM_032960.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.643566"/>
<dbReference type="UniGene" id="Hs.713747"/>
<dbReference type="PDB" id="1KWP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=1-400"/>
</dbReference>
<dbReference type="PDB" id="1NXK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C/D=1-400"/>
</dbReference>
<dbReference type="PDB" id="1NY3">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=1-400"/>
</dbReference>
<dbReference type="PDB" id="2JBO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=41-364"/>
</dbReference>
<dbReference type="PDB" id="2JBP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.31"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L=41-364"/>
</dbReference>
<dbReference type="PDB" id="2OKR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C/F=370-393"/>
</dbReference>
<dbReference type="PDB" id="2ONL">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="C/D=1-400"/>
</dbReference>
<dbReference type="PDB" id="2OZA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=47-400"/>
</dbReference>
<dbReference type="PDB" id="2P3G">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="X=45-371"/>
</dbReference>
<dbReference type="PDB" id="2PZY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D=41-364"/>
</dbReference>
<dbReference type="PDB" id="3A2C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L=41-364"/>
</dbReference>
<dbReference type="PDB" id="3FPM">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=41-364"/>
</dbReference>
<dbReference type="PDB" id="3FYJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="X=45-371"/>
</dbReference>
<dbReference type="PDB" id="3FYK">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="X=45-371"/>
</dbReference>
<dbReference type="PDB" id="3GOK">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L=41-364"/>
</dbReference>
<dbReference type="PDB" id="3KA0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=47-366"/>
</dbReference>
<dbReference type="PDB" id="3KC3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L=41-364"/>
</dbReference>
<dbReference type="PDB" id="3KGA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=47-364"/>
</dbReference>
<dbReference type="PDB" id="3M2W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.41"/>
<property type="chains" value="A=47-364"/>
</dbReference>
<dbReference type="PDB" id="3M42">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.68"/>
<property type="chains" value="A=47-364"/>
</dbReference>
<dbReference type="PDB" id="3R2B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L=47-364"/>
</dbReference>
<dbReference type="PDB" id="3R2Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=46-364"/>
</dbReference>
<dbReference type="PDB" id="3R30">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=46-364"/>
</dbReference>
<dbReference type="PDB" id="3WI6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.99"/>
<property type="chains" value="A/B/C/D/E/F=41-364"/>
</dbReference>
<dbReference type="PDBsum" id="1KWP"/>
<dbReference type="PDBsum" id="1NXK"/>
<dbReference type="PDBsum" id="1NY3"/>
<dbReference type="PDBsum" id="2JBO"/>
<dbReference type="PDBsum" id="2JBP"/>
<dbReference type="PDBsum" id="2OKR"/>
<dbReference type="PDBsum" id="2ONL"/>
<dbReference type="PDBsum" id="2OZA"/>
<dbReference type="PDBsum" id="2P3G"/>
<dbReference type="PDBsum" id="2PZY"/>
<dbReference type="PDBsum" id="3A2C"/>
<dbReference type="PDBsum" id="3FPM"/>
<dbReference type="PDBsum" id="3FYJ"/>
<dbReference type="PDBsum" id="3FYK"/>
<dbReference type="PDBsum" id="3GOK"/>
<dbReference type="PDBsum" id="3KA0"/>
<dbReference type="PDBsum" id="3KC3"/>
<dbReference type="PDBsum" id="3KGA"/>
<dbReference type="PDBsum" id="3M2W"/>
<dbReference type="PDBsum" id="3M42"/>
<dbReference type="PDBsum" id="3R2B"/>
<dbReference type="PDBsum" id="3R2Y"/>
<dbReference type="PDBsum" id="3R30"/>
<dbReference type="PDBsum" id="3WI6"/>
<dbReference type="ProteinModelPortal" id="P49137"/>
<dbReference type="SMR" id="P49137">
<property type="residue range" value="51-390"/>
</dbReference>
<dbReference type="BioGrid" id="114683">
<property type="interactions" value="36"/>
</dbReference>
<dbReference type="DIP" id="DIP-35671N"/>
<dbReference type="IntAct" id="P49137">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="MINT" id="MINT-1539725"/>
<dbReference type="STRING" id="9606.ENSP00000356070"/>
<dbReference type="BindingDB" id="P49137"/>
<dbReference type="ChEMBL" id="CHEMBL2208"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2094"/>
<dbReference type="PhosphoSite" id="P49137"/>
<dbReference type="DMDM" id="1346538"/>
<dbReference type="MaxQB" id="P49137"/>
<dbReference type="PaxDb" id="P49137"/>
<dbReference type="PRIDE" id="P49137"/>
<dbReference type="DNASU" id="9261"/>
<dbReference type="Ensembl" id="ENST00000294981">
<molecule id="P49137-2"/>
<property type="protein sequence ID" value="ENSP00000294981"/>
<property type="gene ID" value="ENSG00000162889"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000367103">
<molecule id="P49137-1"/>
<property type="protein sequence ID" value="ENSP00000356070"/>
<property type="gene ID" value="ENSG00000162889"/>
</dbReference>
<dbReference type="GeneID" id="9261"/>
<dbReference type="KEGG" id="hsa:9261"/>
<dbReference type="UCSC" id="uc001hel.2">
<molecule id="P49137-2"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc001hem.2">
<molecule id="P49137-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9261"/>
<dbReference type="GeneCards" id="GC01P206858"/>
<dbReference type="HGNC" id="HGNC:6887">
<property type="gene designation" value="MAPKAPK2"/>
</dbReference>
<dbReference type="HPA" id="CAB010297"/>
<dbReference type="HPA" id="HPA045556"/>
<dbReference type="MIM" id="602006">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P49137"/>
<dbReference type="PharmGKB" id="PA30631"/>
<dbReference type="eggNOG" id="COG0515"/>
<dbReference type="GeneTree" id="ENSGT00770000120509"/>
<dbReference type="HOGENOM" id="HOG000233031"/>
<dbReference type="HOVERGEN" id="HBG106948"/>
<dbReference type="InParanoid" id="P49137"/>
<dbReference type="KO" id="K04443"/>
<dbReference type="OMA" id="LQMLQDC"/>
<dbReference type="OrthoDB" id="EOG786H3M"/>
<dbReference type="PhylomeDB" id="P49137"/>
<dbReference type="TreeFam" id="TF312891"/>
<dbReference type="BioCyc" id="MetaCyc:HS08751-MONOMER"/>
<dbReference type="BRENDA" id="2.7.11.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="REACT_12065">
<property type="pathway name" value="p38MAPK events"/>
</dbReference>
<dbReference type="Reactome" id="REACT_12524">
<property type="pathway name" value="CREB phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="REACT_150420">
<property type="pathway name" value="Synthesis of Leukotrienes (LT) and Eoxins (EX)"/>
</dbReference>
<dbReference type="Reactome" id="REACT_169436">
<property type="pathway name" value="Oxidative Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="REACT_200780">
<property type="pathway name" value="Regulation of HSF1-mediated heat shock response"/>
</dbReference>
<dbReference type="Reactome" id="REACT_21399">
<property type="pathway name" value="activated TAK1 mediates p38 MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="REACT_228166">
<property type="pathway name" value="VEGFA-VEGFR2 Pathway"/>
</dbReference>
<dbReference type="Reactome" id="REACT_24915">
<property type="pathway name" value="Butyrate Response Factor 1 (BRF1) destabilizes mRNA"/>
</dbReference>
<dbReference type="Reactome" id="REACT_25064">
<property type="pathway name" value="Tristetraprolin (TTP) destabilizes mRNA"/>
</dbReference>
<dbReference type="SignaLink" id="P49137"/>
<dbReference type="ChiTaRS" id="MAPKAPK2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P49137"/>
<dbReference type="GeneWiki" id="MAPKAPK2"/>
<dbReference type="GenomeRNAi" id="9261"/>
<dbReference type="NextBio" id="34715"/>
<dbReference type="PRO" id="PR:P49137"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="P49137"/>
<dbReference type="CleanEx" id="HS_MAPKAPK2"/>
<dbReference type="Genevestigator" id="P49137"/>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="IDA:HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular vesicular exosome"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004871">
<property type="term" value="F:signal transducer activity"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0070935">
<property type="term" value="P:3'-UTR-mediated mRNA stabilization"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019369">
<property type="term" value="P:arachidonic acid metabolic process"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="IMP:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035924">
<property type="term" value="P:cellular response to vascular endothelial growth factor stimulus"/>
<property type="evidence" value="IMP:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031572">
<property type="term" value="P:G2 DNA damage checkpoint"/>
<property type="evidence" value="IMP:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010467">
<property type="term" value="P:gene expression"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048839">
<property type="term" value="P:inner ear development"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006691">
<property type="term" value="P:leukotriene metabolic process"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0044351">
<property type="term" value="P:macropinocytosis"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016071">
<property type="term" value="P:mRNA metabolic process"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002756">
<property type="term" value="P:MyD88-independent toll-like receptor signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048011">
<property type="term" value="P:neurotrophin TRK receptor signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007265">
<property type="term" value="P:Ras protein signal transduction"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032675">
<property type="term" value="P:regulation of interleukin-6 production"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032680">
<property type="term" value="P:regulation of tumor necrosis factor production"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034097">
<property type="term" value="P:response to cytokine"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006950">
<property type="term" value="P:response to stress"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016070">
<property type="term" value="P:RNA metabolic process"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0044281">
<property type="term" value="P:small molecule metabolic process"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051403">
<property type="term" value="P:stress-activated MAPK cascade"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034166">
<property type="term" value="P:toll-like receptor 10 signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034134">
<property type="term" value="P:toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034138">
<property type="term" value="P:toll-like receptor 3 signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034142">
<property type="term" value="P:toll-like receptor 4 signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034146">
<property type="term" value="P:toll-like receptor 5 signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034162">
<property type="term" value="P:toll-like receptor 9 signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038123">
<property type="term" value="P:toll-like receptor TLR1:TLR2 signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038124">
<property type="term" value="P:toll-like receptor TLR6:TLR2 signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="IMP:BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.1170.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027442">
<property type="entry name" value="MAPKAPK_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002290">
<property type="entry name" value="Ser/Thr_dual-sp_kinase"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="MAP kinase-activated protein kinase 2" id="PRO_0000086288">
<location>
<begin position="1"/>
<end position="400"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="11">
<location>
<begin position="64"/>
<end position="325"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="11">
<location>
<begin position="70"/>
<end position="78"/>
</location>
</feature>
<feature type="region of interest" description="Staurosporine binding">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="region of interest" description="Autoinhibitory helix" evidence="10">
<location>
<begin position="328"/>
<end position="364"/>
</location>
</feature>
<feature type="region of interest" description="p38 MAPK-binding site">
<location>
<begin position="366"/>
<end position="390"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal (NES)">
<location>
<begin position="356"/>
<end position="365"/>
</location>
</feature>
<feature type="short sequence motif" description="Bipartite nuclear localization signal 1">
<location>
<begin position="371"/>
<end position="374"/>
</location>
</feature>
<feature type="short sequence motif" description="Bipartite nuclear localization signal 2">
<location>
<begin position="385"/>
<end position="389"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="10"/>
<end position="40"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="35"/>
<end position="40"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor">
<location>
<position position="186"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="11">
<location>
<position position="93"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="37">
<location>
<position position="9"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="37">
<location>
<position position="25"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK14" evidence="37">
<location>
<position position="222"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK14" evidence="37">
<location>
<position position="272"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="10">
<location>
<position position="328"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK14" evidence="37">
<location>
<position position="334"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)">
<location>
<position position="353"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_004910" evidence="38">
<original>EEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH</original>
<variation>GCLHDKNSDQATWLTRL</variation>
<location>
<begin position="354"/>
<end position="400"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35671930." id="VAR_040753" evidence="25">
<original>A</original>
<variation>G</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55894011." id="VAR_040754" evidence="25">
<original>A</original>
<variation>S</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="mutagenesis site" description="Kinase defective mutant, abolishes activity." evidence="18">
<original>K</original>
<variation>R</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="mutagenesis site" description="Kinase defective mutant, abolishes activity." evidence="37">
<original>D</original>
<variation>A</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strong decrease in kinase activity." evidence="18 19 37">
<original>T</original>
<variation>A</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimicks phosphorylation state, leading to slight increase of basal kinase activity." evidence="18 19 37">
<original>T</original>
<variation>D</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimicks phosphorylation state and constitutive protein kinase activity; when associated with E-334." evidence="18 19 37">
<original>T</original>
<variation>E</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strong decrease in kinase activity." evidence="37">
<original>S</original>
<variation>A</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimicks phosphorylation state, leading to slight increase of basal kinase activity." evidence="37">
<original>S</original>
<variation>D</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight decrease in kinase activity." evidence="18 19 37">
<original>T</original>
<variation>A</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimicks phosphorylation state, leading to elevated basal kinase activity." evidence="18 19 37">
<original>T</original>
<variation>D</variation>
<variation>E</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimicks phosphorylation state and constitutive protein kinase activity; when associated with E-222." evidence="18 19 37">
<original>T</original>
<variation>E</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces decreased sumoylation and increase in protein kinase activity." evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="353"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; CAA53094." ref="5" evidence="39">
<original>H</original>
<variation>D</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; CAA53094." ref="5" evidence="39">
<original>WS</original>
<variation>LV</variation>
<location>
<begin position="247"/>
<end position="248"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="45"/>
<end position="47"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="48"/>
<end position="50"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="59"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="63"/>
<end position="73"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="76"/>
<end position="83"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="84"/>
<end position="86"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="89"/>
<end position="96"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="99"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="114"/>
<end position="117"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="120"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="131"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="143"/>
<end position="145"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="146"/>
<end position="152"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="160"/>
<end position="179"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="189"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="192"/>
<end position="198"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="203"/>
<end position="205"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="212"/>
<end position="214"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="228"/>
<end position="230"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="232"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="239"/>
<end position="242"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="243"/>
<end position="258"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="267"/>
<end position="269"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="275"/>
<end position="281"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="283"/>
<end position="285"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="288"/>
<end position="291"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="296"/>
<end position="305"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="310"/>
<end position="312"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="316"/>
<end position="320"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="323"/>
<end position="326"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="328"/>
<end position="330"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="335"/>
<end position="337"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="338"/>
<end position="344"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="346"/>
<end position="348"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="349"/>
<end position="363"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="375"/>
<end position="377"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="381"/>
<end position="389"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1KWP"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1NXK"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OKR"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OZA"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3FPM"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3FYK"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3M2W"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3M42"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WI6"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10383393"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11844797"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12171911"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12456657"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12565831"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14499342"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14517288"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15014438"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15094067"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15629715"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16278218"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16456544"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17255097"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17395714"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17449059"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17480064"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17481585"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17576063"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18021073"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20932473"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21131586"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8093612"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8280084"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8774846"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8846784"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8179591"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305"/>
<sequence length="400" mass="45568" checksum="E4EFFF11CCF288DC" modified="1996-02-01" version="1">
MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII
DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRI
VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI
NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY
DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM
LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL
ATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>